
CYTOTOOLS
Share · DE000A0KFRJ1 · A0KFRJ (XFRA)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | -33,61 % | -96,88 % |
Company Profile for CYTOTOOLS Share
CytoTools AG, a biotechnology company, develops a pipeline of disease modifying therapies. The company's therapies include proprietary small molecules and biologics to provide treatment options in dermatology, cardiology and angiology, urology, and oncology. Its lead clinical product is DermaPro that has completed Phase III clinical trials for the treatment of diabetic foot ulcers in India; is in Phase III clinical trials for diabetic foot ulcer treatment in Europe; and is in Phase II/III clinical studies for the treatment of venous leg ulcers in Germany, as well as is used as an anti-infective. The company also develops Utisept, an urological medical device for flushing the bladder in urinary tract infections; Derma MP for the treatment of venous leg ulcers in Europe; CardioClean that is in preclinical stage for the treatment of restenosis, diabetis, and carotis-stenosis; and Cancer T17-n for cancer treatment in Europe. CytoTools has collaboration agreement with Activoris Medizintechnik GmbH to develop inhalation therapy for viral infections, such as COVID-19 and influenza. CytoTools AG was founded in 2000 and is based in Darmstadt, Germany.
Company Data
Name CYTOTOOLS
Company CytoTools AG
Website
https://cytotools.de
Primary Exchange
Frankfurt

WKN A0KFRJ
ISIN DE000A0KFRJ1
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Dirk Kaiser
Country Germany
Currency EUR
Employees 0,0 T
Address Klappacher Strasse 126, 64285 Darmstadt
IPO Date 2006-12-18
Stock Splits
Date | Split |
---|---|
12.08.2024 | 1:10 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | T5O.F |
XETRA | T5O.DE |
More Shares
Investors who CYTOTOOLS hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.